NXT-Dx

Gentbrugge, Belgium Founded: 2011 • Age: 15 yrs Acquired By Diagenode
Epigenetics services are offered to life science researchers.
Request Access

About NXT-Dx

NXT-Dx is a company based in Gentbrugge (Belgium) founded in 2011 by Maarten Braspenning was acquired by Diagenode in August 2018.. NXT-Dx operates in a competitive market with competitors including Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others.

  • Headquarter Gentbrugge, Belgium
  • Founders Maarten Braspenning
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Diagenode

    (Aug 16, 2018)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NXT-Dx

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in NXT-Dx

NXT-Dx has secured backing from 1 investor. Prominent investors backing the company include Diagenode. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Reagents and kits for epigenetics sequencing solutions are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by NXT-Dx

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - NXT-Dx

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Nxt-Dx Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of NXT-Dx

NXT-Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Depixus, Genomics, Seven Bridges Genomics, Hexagon Bio and BC Platforms, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Single-molecule genetic and epigenetic sequencing solutions are provided.
domain founded_year HQ Location
Genomic risk assessment and prevention platform is provided.
domain founded_year HQ Location
Cloud-based platform to analyze, store, and act on genomic data.
domain founded_year HQ Location
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
domain founded_year HQ Location
Platforms for genomic data analysis and management are provided.
domain founded_year HQ Location
Gene-editing platform and anti-aging therapy for dogs are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Nxt-Dx

Frequently Asked Questions about NXT-Dx

When was NXT-Dx founded?

NXT-Dx was founded in 2011.

Where is NXT-Dx located?

NXT-Dx is headquartered in Gentbrugge, Belgium. It is registered at Gentbrugge, East Flanders, Belgium.

What does NXT-Dx do?

NXT-Dx was founded in 2011 and is based in Gentbrugge, Belgium. Services in epigenetics are provided to the life science community, including Infinium Methylation EPIC array, MBD-sequencing, MeDIP-seq, Reduced Representation Bisulfite Sequencing, and bisulfite sequencing variants for targeted, genome-wide, or whole-genome analysis. Additional offerings encompass genomics, transcriptomics, metagenomics, and bioinformatics support. Operations focus on advancing epigenetic and related genomic studies.

Who are the top competitors of NXT-Dx?

NXT-Dx's top competitors include Novogene Corporation, Depixus and Ingenuity Systems.

Who are NXT-Dx's investors?

NXT-Dx has 1 investor. Key investors include Diagenode.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available